Myriad Genetics
MYGN
#6699
Rank
$0.66 B
Marketcap
$7.09
Share price
-3.27%
Change (1 day)
-56.66%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -$0.42 Billion USD

According to Myriad Genetics's latest financial reports the company's current earnings are $0.82 Billion USD. In 2024 the company made an earning of -$0.13 Billion USD, an increase over its 2023 earnings that were of -$0.26 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.42 Billion247.01%
2024 -$0.13 Billion-53.49%
2023 -$0.26 Billion88.72%
2022 -$0.14 Billion172.08%
2021 -$50.5 Million
2019 -$26.3 Million-175.14%
2018 $35 M-70.81%
2017 $0.11 B22.22%
2016 $98.1 M-38.8%
2015 $0.16 B-6.12%
2014 $0.17 B-41.07%
2013 $0.28 B46.67%
2012 $0.19 B15.84%
2011 $0.17 B17.6%
2010 $0.14 B-15.96%
2009 $0.17 B
2007 -$41.68 Million40.96%
2006 -$29.57 Million
2003 -$34.34 Million34.8%
2002 -$25.48 Million89.21%
2001 -$13.47 Million3.93%
2000 -$12.96 Million21.76%
1999 -$10.64 Million-25.61%
1998 -$14.3 Million38.83%
1997 -$10.3 Million-24.26%
1996 -$13.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-$0.85 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-$0.98 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-$34.97 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.67 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.13 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA